{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:02:37Z","timestamp":1784530957502,"version":"3.55.0"},"reference-count":45,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Med Insights Cardiol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sodium-glucose transporter 2 (SGLT2) inhibitors have shown significant cardiovascular benefits in heart failure (HF) patients with diabetes mellitus or chronic kidney disease. However, their safety and efficacy in non-diabetic patients without HF presenting with acute myocardial infarction (AMI) remain understudied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Databases including MEDLINE, Scopus, Cochrane Library, and ClinicalTrials.gov were queried through August 2025 to identify randomized controlled trials (RCTs). Data were pooled using a random-effects model using risk ratios (RR) and mean differences (MD) with 95% confidence intervals (CI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five RCTs involving 9,135 patients (SGLT2i: 4,581 and placebo: 4,554) were included. On pooled analysis, SGLT2 inhibitors were associated with significantly reduced first HF hospitalization (RR: 0.74, p=0.02), improved LVEF (MD: 2.08; p=0.002), and reduced NT-proBNP levels (MD: 12.81; p &lt; 0.0001). No significant differences were noted in all-cause mortality and the composite of first HF hospitalization with all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In non-diabetic patients without HF, SGLT2 inhibitors significantly reduce the first HF hospitalization and improve LVEF following AMI. The findings of this meta-analysis suggest that future research should evaluate the cardiovascular benefits of SGLT2 inhibitors in this patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/11795468261469143","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:53:53Z","timestamp":1784292833000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Sodium-Glucose Cotransporter-2 Inhibitors Following Acute Myocardial Infarction in Patients Without Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1177","volume":"20","author":[{"given":"Muhammad","family":"Ahmed","sequence":"first","affiliation":[{"name":"Dow University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3829-7298","authenticated-orcid":false,"given":"Muhammad Hamza","family":"Shuja","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shajia","family":"Shakil","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huzaifa","family":"Ul Haque Ansari","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firzah","family":"Shakil","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Abdullah Naveed","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Atta","family":"Ur Rehman","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narmeen","family":"Shaikh","sequence":"additional","affiliation":[{"name":"Alfaisal University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Hassaan","family":"Ali","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haya Waseem","family":"Ansari","sequence":"additional","affiliation":[{"name":"Liaquat National Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Sajid","sequence":"additional","affiliation":[{"name":"Liaquat National Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Murtaza","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Usman","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8285-6233","authenticated-orcid":false,"given":"Biruk Demisse","family":"Ayalew","sequence":"additional","affiliation":[{"name":"St. Paul\u2019s Hospital Millennium Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.1001453"},{"key":"e_1_3_3_3_2","unstructured":"Myocardial infarction | Radiology Reference Article | Radiopaedia.org [Internet]. [cited 2025 Jul 29]. Available from: https:\/\/radiopaedia.org\/articles\/myocardial-infarction"},{"key":"e_1_3_3_4_2","volume-title":"Myocardial Infarction","author":"Ojha N","year":"2023","unstructured":"Ojha N, Dhamoon AS. Myocardial Infarction. StatPearls; 2023. [cited 2025 Jul 29]; Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537076\/"},{"key":"e_1_3_3_5_2","unstructured":"Heart Attack: Symptoms & Treatment [Internet]. [cited 2025 Jul 29]. Available from: https:\/\/my.clevelandclinic.org\/health\/diseases\/16818-heart-attack-myocardial-infarction"},{"key":"e_1_3_3_6_2","volume-title":"Percutaneous Coronary Intervention","author":"Ahmad M","year":"2023","unstructured":"Ahmad M, Mehta P, Reddivari AKR, Mungee S. Percutaneous Coronary Intervention. StatPearls [Internet]; 2023. [cited 2025 Jul 29]; Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK556123\/"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/14796678.2024.2387516"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S212003"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2022.03.005"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2024.100927"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-020-00809-4"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2024.02.039"},{"key":"e_1_3_3_13_2","volume-title":"Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors","author":"Padda IS","year":"2023","unstructured":"Padda IS, Mahtani AU, Parmar M. Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors. StatPearls; 2023. [cited 2025 Jul 29]; Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK576405\/"},{"key":"e_1_3_3_14_2","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021. [cited 2025 Jul 29];372. Available from: https:\/\/www.bmj.com\/content\/372\/bmj.n71","journal-title":"BMJ"},{"key":"e_1_3_3_15_2","unstructured":"RoB 2. A revised Cochrane risk-of-bias tool for randomized trials | Cochrane Bias. [Internet]. [cited 2025 Jul 29]. Available from: https:\/\/methods.cochrane.org\/bias\/resources\/rob-2-revised-cochrane-risk-bias-tool-randomized-trials"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.03.002"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300286"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-024-00662-4"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2314051"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac494"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02074-8"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.31083\/RCM26136"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2024.102648"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-024-10457-z"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1594861"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02592-0"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000001576"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100933"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells14090668"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01480-1"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073651"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02777-7"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.12997\/jla.2022.11.1.1"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568026611313020002"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2017.04.004"},{"key":"e_1_3_3_37_2","article-title":"NT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction Is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI Trial","author":"Jering KS","year":"2025","unstructured":"Jering KS, Claggett BL, Braunwald E, et al. NT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction Is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI Trial. J Card Fail [Internet]. 2025. [cited 2025 Jul 30];0(0). Available from: https:\/\/onlinejcf.com\/action\/showFullText?pii=S1071916425001642","journal-title":"J Card Fail [Internet]"},{"key":"e_1_3_3_38_2","unstructured":"Left Ventricular Ejection Fraction - StatPearls - NCBI Bookshelf [Internet]. [cited 2025 Jul 30]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459131\/"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2024.01.017"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijpvm.IJPVM_122_20"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12727"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2022.28.2.157"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1080\/14796678.2025.2464449"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02000-5"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcab065"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcrp.2025.200370"}],"container-title":["Clinical Medicine Insights: Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11795468261469143","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11795468261469143","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11795468261469143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:17:43Z","timestamp":1784528263000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11795468261469143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":45,"alternative-id":["10.1177\/11795468261469143"],"URL":"https:\/\/doi.org\/10.1177\/11795468261469143","relation":{},"ISSN":["1179-5468","1179-5468"],"issn-type":[{"value":"1179-5468","type":"print"},{"value":"1179-5468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"article-number":"11795468261469143"}}